Sashi Kiran Inkollu, MBBS

Sashi Inkollu practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Sashi Inkollu's NPI, 1235368606, was assigned on July 7, 2009. Sashi Inkollu graduated from Gandhi Medical College in 2003. Sashi Inkollu holds Florida license ME169486.

Sashi Inkollu's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Sashi Inkollu's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Sashi Inkollu is also affiliated with Tampa General Hospital. The medical group on file is University Health Associates. Dmand AI also links Sashi Inkollu to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sashi Inkollu practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Sashi Inkollu's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Sashi Inkollu is board certified in surgery by the American Board of Surgery. Dmand AI has Sashi Inkollu's licenses on file in 8 states: Florida, Ohio, West Virginia, Maryland, Pennsylvania, Wisconsin, Texas and Missouri.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT) and heart device and aorta surgery among the conditions Sashi Inkollu treats.

CMS data shows 640 Medicare services from Sashi Inkollu across 14 procedure codes in 2024, for 567 Medicare patients. Medicare paid $21,194 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 567 Medicare patients who saw Sashi Inkollu in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sashi Inkollu's median patient age at 69, with 39% women.

In 2024, Sashi Inkollu wrote 50 Medicare Part D claims for 30 patients. 74% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each, at $407 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Sashi Inkollu for performance year 2024, reported through an alternative payment model (APM). Sashi Inkollu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sashi Inkollu as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Sashi Inkollu, published from 2015 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Arteriovenous Shunt, Surgical, Renal Dialysis and Thrombosis. Sashi Inkollu has published most often in Ann Vasc Surg. Sashi Inkollu's most frequent co-authors are Carlos Fares Bechara, MD, Yusuf Musa Chauhan, MD and Jason H. Hwang, DO.

CMS Open Payments shows 105 general payments to Sashi Inkollu from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Medtronic, Inc. paid the most, $2,146.

Dmand AI lists 2 awards for Sashi Inkollu, most recently Top Gun, Laparoscopic competition finalist during Residency in 2015.

Sashi Inkollu graduated from Gandhi Medical College in 2003.

Sashi Inkollu is in network with 19 carriers, including Aetna, Elevance and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.